Clinical Trial Update: The Mito-Frail Trial: Effects of MitoQ on Vasodilation, Mobility and Cognitive Performance in Frail Older Adults [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating the effects of MitoQ on vasodilation, mobility, and cognitive performance in frail older adults is currently recruiting at UConn Heal…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Impairment
• Frailty

Drugs mentioned

• MitoQ

Snippet

Sponsor: UConn Health | Conditions: Frailty, Mild Cognitive Impairment | Phase 2 | Status: RECRUITING